Cargando…

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma

OBJECTIVES: The resection status is one of the most important prognostic factors for patients with head and neck squamous cell carcinoma (HNSCC) concerning overall survival (OS) and recurrence free interval (RFI). To assess whether therapy concepts changed depending on different resection margins an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Backes, Clara, Bier, Henning, Knopf, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663598/ https://www.ncbi.nlm.nih.gov/pubmed/29137426 http://dx.doi.org/10.18632/oncotarget.21035

Ejemplares similares

Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma
por: Knopf, Andreas, et al.
Publicado: (2021)

Primary tumor-associated expression of CXCR4 predicts formation of local and systemic recurrency in head and neck squamous cell carcinoma
por: Knopf, Andreas, et al.
Publicado: (2017)

Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck
por: Jacobi, Christian, et al.
Publicado: (2014)

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
por: Phillips, T. J., et al.
Publicado: (2019)

Bilateral versus ipsilateral neck dissection in oral and oropharyngeal cancer with contralateral cN0 neck
por: Knopf, Andreas, et al.
Publicado: (2020)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma
por: Shiah, Shine-Gwo, et al.
Publicado: (2021)

Recurrence and Disease-Free Survival in Head and Neck Squamous Cell Carcinoma After Margin-Free Resection on Frozen Section: An Institutional Perspective
por: Hashmi, Atif A, et al.
Publicado: (2020)

Aurora Kinase Inhibition Overcomes Cetuximab Resistance in Squamous Cell Cancer of the Head and Neck
por: Hoellein, Alexander, et al.
Publicado: (2011)

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
por: Laban, Simon, et al.
Publicado: (2017)

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
por: Rühle, Alexander, et al.
Publicado: (2023)

The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
por: Fritsche, Marie Kristin, et al.
Publicado: (2017)

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas
por: Sablin, Marie-Paule, et al.
Publicado: (2016)

Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma
por: Castellano, Lúcio Roberto Cançado, et al.
Publicado: (2022)

Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
por: Pazhani, Jayanthi, et al.
Publicado: (2023)

Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas
por: Meireles Da Costa, Nathalia, et al.
Publicado: (2021)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma
por: Zhuang, Zehang, et al.
Publicado: (2020)

The Effect of the Surgical Margins on the Outcome of Patients with Head and Neck Squamous Cell Carcinoma: Single Institution Experience
por: Eldeeb, Hany, et al.
Publicado: (2012)

Telomerase Activity Levels in the Surgical Margin and Tumour Distant Tissue of the Squamous Cell Carcinoma of the Head-And-Neck
por: Fabricius, Eva‐Maria, et al.
Publicado: (2002)

The non-coding landscape of head and neck squamous cell carcinoma
por: Zou, Angela E., et al.
Publicado: (2016)

Human Mesenchymal Stromal Cells Do Not Cause Radioprotection of Head-and-Neck Squamous Cell Carcinoma
por: Rühle, Alexander, et al.
Publicado: (2022)

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma
por: Cao, Wei, et al.
Publicado: (2016)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
por: Devaraja, K., et al.
Publicado: (2023)

T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications
por: Meng, Zilu, et al.
Publicado: (2023)

The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN)
por: Scheckenbach, Kathrin, et al.
Publicado: (2010)

Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
por: Bao, Jiantong, et al.
Publicado: (2023)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Nectin-4 is widely expressed in head and neck squamous cell carcinoma
por: Sanders, Christine, et al.
Publicado: (2022)

Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas
por: Colacino, Justin A., et al.
Publicado: (2012)

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma
por: Lechner, Axel, et al.
Publicado: (2017)

Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry
por: Schmidt, Janos, et al.
Publicado: (2020)

Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma
por: Zhang, Jian, et al.
Publicado: (2020)

Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma
por: Schutt, Charles R., et al.
Publicado: (2021)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
por: Knauer, Shirley K.
Publicado: (2009)

Identification of potential therapeutic targets in human head & neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4g1vq17cmbhuhbs40vpj8k8ej3